| Stage | LLY | % of rev | AMGN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $24.4B | 100.00% | $10.4B | 100.00% | LLY ×2.35 |
| Gross profit | $20.5B | 83.88% | $7.6B | 73.10% | LLY +10.8pp |
| Operating income | $8.6B | 35.28% | $3.7B | 35.79% | AMGN +0.5pp |
| Pre-tax income | $8.4B | 34.46% | $4.7B | 45.21% | AMGN +10.8pp |
| Net income | $6.5B | 26.44% | $3.9B | 37.28% | AMGN +10.8pp |
| Stage | LLY | AMGN | Gap · A − B |
|---|---|---|---|
| Revenue | $24.4B100.00% | $10.4B100.00% | LLY ×2.35 |
| Gross profit | 83.88%$20.5B | 73.10%$7.6B | LLY +10.8pp |
| Operating income | 35.28%$8.6B | 35.79%$3.7B | AMGN +0.5pp |
| Pre-tax income | 34.46%$8.4B | 45.21%$4.7B | AMGN +10.8pp |
| Net income |
| 26.44%$6.5B |
| 37.28%$3.9B |
| AMGN +10.8pp |
No shared counterparties.